IL17A and myeloid sarcoma: Findings regarding acetate in MS are conflicting: elevated acetate levels have been associated with higher expanded disability status scale (EDSS) and MSSS values, along with an increase in IL-17-producing CD8+ T cells and a reduction in naïve CD4+ T cells [111]; however, other reports describe a beneficial association between acetate levels and disease activity [112].